Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Sherpa Roméo
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Infrastructure nationale du savoir de Chine (CNKI)
  • Bibliothèque de revues électroniques
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catalogue en ligne SWB
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

Total Synthesis based with the Natural Furanonaphthoquinone Scaffold and their Biological activity evaluation

Chik Wai I

Furanonaphthoquinones (FNQs) are a group of small molecules that have been found to exhibit a variety of biological activities, including antimicrobial and anticancer activities. Their natural occurrence include plants of the Bignoniaceae family. Bioactivity-guided fractionation and isolation of Radermachera boniana Dop led to the separation and identification of napabucasin, which is a cytotoxic FNQ that can selectively target cancer stemness and metastasis. The study of napabucasin has been extensive and according to the National Cancer Institute, napabucasin is currently involved in several active clinical trials for treating cancer, including advanced and metastatic colorectal cancer. To cope with the increasing demand of an effective synthesis approach for the lead compound for its further development into a drug candidate, a facile and economic total synthesis route has been established. Moverover, derivatives of napabucasin have been synthesized in order to study the structure-activity relationship (SAR) so as to provide evidence for lead optimization and also for unraveling the mechanism of action.